logo

LSB

LakeShore Biopharma
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

LSB Profile

Lakeshore Biopharma Co., Ltd

A global biopharmaceutical company developing next-generation vaccines and therapeutics

Pharmaceutical
Invalid Date
08/05/2021
NASDAQ Stock Exchange
758
03-31
Common stock
Building No. 2, 38 Yongda Road, Daxing Biomedical Industry Park, Daxing District, Beijing, PRC 102629
--
Lakeshore Biopharmaceuticals Limited was incorporated as an exempted limited liability company under the laws of the Cayman Islands in November 2020. Lakeshore Biopharmaceuticals Limited is a global biopharmaceutical company dedicated to the discovery, development, manufacture and commercialization of next-generation vaccines and therapeutic biological agents for infectious diseases and cancer. The company has developed a proprietary PIKA immunomodulation technology platform, as well as a range of biological agents for the prevention and treatment of rabies, hepatitis B, herpes zoster, influenza, and coronavirus.